Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 18

1.

Endogenous dopamine (DA) competes with the binding of a radiolabeled D₃ receptor partial agonist in vivo: a positron emission tomography study.

Mach RH, Tu Z, Xu J, Li S, Jones LA, Taylor M, Luedtke RR, Derdeyn CP, Perlmutter JS, Mintun MA.

Synapse. 2011 Aug;65(8):724-32. doi: 10.1002/syn.20891. Epub 2011 Mar 21.

2.

Radiosynthesis and ex vivo evaluation of (R)-(-)-2-chloro-N-[1-11C-propyl]n-propylnorapomorphine.

Palner M, McCormick P, Gillings N, Begtrup M, Wilson AA, Knudsen GM.

Nucl Med Biol. 2010 Jan;37(1):35-40. doi: 10.1016/j.nucmedbio.2009.08.005. Epub 2009 Oct 3.

PMID:
20122666
3.

Amphetamine-induced displacement of [18F] fallypride in striatum and extrastriatal regions in humans.

Riccardi P, Li R, Ansari MS, Zald D, Park S, Dawant B, Anderson S, Doop M, Woodward N, Schoenberg E, Schmidt D, Baldwin R, Kessler R.

Neuropsychopharmacology. 2006 May;31(5):1016-26.

4.

The striatal and extrastriatal D2/D3 receptor-binding profile of clozapine in patients with schizophrenia.

Gründer G, Landvogt C, Vernaleken I, Buchholz HG, Ondracek J, Siessmeier T, Härtter S, Schreckenberger M, Stoeter P, Hiemke C, Rösch F, Wong DF, Bartenstein P.

Neuropsychopharmacology. 2006 May;31(5):1027-35.

5.
6.

Learning networks in health and Parkinson's disease: reproducibility and treatment effects.

Carbon M, Ghilardi MF, Feigin A, Fukuda M, Silvestri G, Mentis MJ, Ghez C, Moeller JR, Eidelberg D.

Hum Brain Mapp. 2003 Jul;19(3):197-211.

PMID:
12811735
7.
8.

Basal ganglia and movement disorders: an update.

Chesselet MF, Delfs JM.

Trends Neurosci. 1996 Oct;19(10):417-22. Review.

PMID:
8888518
9.

Affinities and intrinsic activities of dopamine receptor agonists for the hD21 and hD4.4 receptors.

Lahti RA, Mutin A, Cochrane EV, Tepper PG, Dijkstra D, Wikström H, Tamminga CA.

Eur J Pharmacol. 1996 Apr 22;301(1-3):R11-3.

PMID:
8773470
11.

Autoradiographic localization of [3H]sulpiride binding sites in the rat brain.

Gehlert DR, Wamsley JK.

Eur J Pharmacol. 1984 Feb 17;98(2):311-2. No abstract available.

PMID:
6714315
12.

Two dopamine receptors: biochemistry, physiology and pharmacology.

Stoof JC, Kebabian JW.

Life Sci. 1984 Dec 3;35(23):2281-96. Review.

PMID:
6390056
13.

Aporphines. 8. Total synthesis and pharmacological evaluation of (plus or minus)-apomorphine, (plus or minus)-apocodeine, (plus or minus)-N-n-propylnorapomorphine, and (plus or minus)-N-n-propylnorapocodeine.

Neumeyer JL, Neustadt BR, Oh KH, Weinhardt KK, Boyce CB, Rosenberg FJ, Teiger DG.

J Med Chem. 1973 Nov;16(11):1223-8. No abstract available.

PMID:
4201182
14.

The functional state of the dopamine receptor in the anterior pituitary is in the high affinity form.

George SR, Watanabe M, Di Paolo T, Falardeau P, Labrie F, Seeman P.

Endocrinology. 1985 Aug;117(2):690-7.

PMID:
4017954
15.

In vitro binding properties and autoradiographic imaging of 3-iodobenzamide ([125I]-IBZM): a potential imaging ligand for D-2 dopamine receptors in SPECT.

Brücke T, Tsai YF, McLellan C, Singhanyom W, Kung HF, Cohen RM, Chiueh CC.

Life Sci. 1988;42(21):2097-104.

PMID:
3260318
16.

Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases.

Seeman P, Bzowej NH, Guan HC, Bergeron C, Reynolds GP, Bird ED, Riederer P, Jellinger K, Tourtellotte WW.

Neuropsychopharmacology. 1987 Dec;1(1):5-15.

PMID:
2908095
17.

Dopamine D2 receptors in the cerebral cortex: distribution and pharmacological characterization with [3H]raclopride.

Lidow MS, Goldman-Rakic PS, Rakic P, Innis RB.

Proc Natl Acad Sci U S A. 1989 Aug;86(16):6412-6.

18.

High affinity dopamine D2 receptor radioligands. 2. [125I]epidepride, a potent and specific radioligand for the characterization of striatal and extrastriatal dopamine D2 receptors.

Kessler RM, Ansari MS, Schmidt DE, de Paulis T, Clanton JA, Innis R, al-Tikriti M, Manning RG, Gillespie D.

Life Sci. 1991;49(8):617-28.

PMID:
1830917

Supplemental Content

Support Center